Skip to main content
Erschienen in: Sleep and Breathing 4/2022

29.11.2021 | Sleep Breathing Physiology and Disorders • Original Article

Gestational chronic intermittent hypoxia induces hypertension, proteinuria, and fetal growth restriction in mice

verfasst von: Cuilian Weng, Long Huang, Hangwei Feng, Quanying He, Xingsheng Lin, Tingting Jiang, Jian Lin, Xincai Wang, Qinghua Liu

Erschienen in: Sleep and Breathing | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pregnant women are predisposed to obstructive sleep apnea (OSA). Based on the fact that OSA is an independent risk factor for hypertension among the general population, we hypothesized that chronic intermittent hypoxia (CIH), as a feature of OSA, may lead to preeclampsia.

Methods

Pregnant and non-pregnant C57BL/6 J mice were exposed to two conditions of chronic intermittent hypoxia: CIH1 (21–5% O2 alternations), CIH2 (21–10% O2 alternations), and room air until day 19.

Results

In non-pregnant mice, compared with their respective baseline values, systolic blood pressure (SBP) started to rise from day 14 in the CIH1 group, and SBP rose until day 19 in the CIH2 group. Compared with the pregnant mice exposed to room air, pregnant mice exposed to CIH1 maintained elevated SBP from day 14, accompanied by proteinuria, fetal and placental growth restriction, and a reduction in the number of fetuses. An imbalance between proangiogenic and antiangiogenic factors and impairment of vascular remodeling existed in the placenta of pregnant mice exposed to CIH1. Maternal serum levels of the soluble form of vascular endothelial growth factor receptor-1 were also significantly increased. Pregnant mice exposed to CIH2 seemed to have milder changes than pregnant mice exposed to CIH1.

Conclusion

Our results demonstrated that gestational CIH may induce gestational hypertension, proteinuria, fetal and placental growth restriction as well as impairments in placental angiogenesis and vascular remodeling.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235CrossRefPubMed Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235CrossRefPubMed
3.
Zurück zum Zitat Louis JM, Koch MA, Reddy UM, Silver RM, Parker CB, Facco FL, Redline S, Nhan-Chang CL, Chung JH, Pien GW, Basner RC, Grobman WA, Wing DA, Simhan HN, Haas DM, Mercer BM, Parry S, Mobley D, Carper B, Saade GR, Schubert FP, Zee PC (2018) Predictors of sleep-disordered breathing in pregnancy. Am J Obstet Gynecol 218(521):e1-521.e12 Louis JM, Koch MA, Reddy UM, Silver RM, Parker CB, Facco FL, Redline S, Nhan-Chang CL, Chung JH, Pien GW, Basner RC, Grobman WA, Wing DA, Simhan HN, Haas DM, Mercer BM, Parry S, Mobley D, Carper B, Saade GR, Schubert FP, Zee PC (2018) Predictors of sleep-disordered breathing in pregnancy. Am J Obstet Gynecol 218(521):e1-521.e12
4.
Zurück zum Zitat Spence DL, Allen RC, Lutgendorf MA, Gary VR, Richard JD, Gonzalez SC (2017) Association of obstructive sleep apnea with adverse pregnancy-related outcomes in military hospitals. Eur J Obstet Gynecol Reprod Biol 210:166–172CrossRefPubMed Spence DL, Allen RC, Lutgendorf MA, Gary VR, Richard JD, Gonzalez SC (2017) Association of obstructive sleep apnea with adverse pregnancy-related outcomes in military hospitals. Eur J Obstet Gynecol Reprod Biol 210:166–172CrossRefPubMed
5.
Zurück zum Zitat Fried G, Samuelson U (1991) Endothelin and neuropeptide Y are vasoconstrictors in human uterine blood vessels. Am J Obstet Gynecol 164:1330–1336CrossRefPubMed Fried G, Samuelson U (1991) Endothelin and neuropeptide Y are vasoconstrictors in human uterine blood vessels. Am J Obstet Gynecol 164:1330–1336CrossRefPubMed
6.
Zurück zum Zitat Lefcourt LA, Rodis JF (1996) Obstructive sleep apnea in pregnancy. Obstet Gynecol Surv 51:503–506CrossRefPubMed Lefcourt LA, Rodis JF (1996) Obstructive sleep apnea in pregnancy. Obstet Gynecol Surv 51:503–506CrossRefPubMed
7.
Zurück zum Zitat Facco FL, Parker CB, Reddy UM, Silver RM, Koch MA, Louis JM, Basner RC, Chung JH, Nhan-Chang CL, Pien GW, Redline S, Grobman WA, Wing DA, Simhan HN, Haas DM, Mercer BM, Parry S, Mobley D, Hunter S, Saade GR, Schubert FP, Zee PC (2017) Association between sleep disordered breathing and hypertensive disorders of pregnancy and gestational diabetes mellitus. Obstet Gynecol 129(1):31–41CrossRefPubMedPubMedCentral Facco FL, Parker CB, Reddy UM, Silver RM, Koch MA, Louis JM, Basner RC, Chung JH, Nhan-Chang CL, Pien GW, Redline S, Grobman WA, Wing DA, Simhan HN, Haas DM, Mercer BM, Parry S, Mobley D, Hunter S, Saade GR, Schubert FP, Zee PC (2017) Association between sleep disordered breathing and hypertensive disorders of pregnancy and gestational diabetes mellitus. Obstet Gynecol 129(1):31–41CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Charbonneau M, Falcone T, Cosio MG, Levy RD (1991) Obstructive sleep apnea during pregnancy. Therapy and implications for fetal health. Am Rev Respir Dis 144:461–463CrossRefPubMed Charbonneau M, Falcone T, Cosio MG, Levy RD (1991) Obstructive sleep apnea during pregnancy. Therapy and implications for fetal health. Am Rev Respir Dis 144:461–463CrossRefPubMed
9.
Zurück zum Zitat Sahin FK, Koken G, Cosar E, Saylan F, Fidan F et al (2008) Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynaecol Obstet 100:141–146CrossRefPubMed Sahin FK, Koken G, Cosar E, Saylan F, Fidan F et al (2008) Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynaecol Obstet 100:141–146CrossRefPubMed
10.
Zurück zum Zitat Brain KA, Thornton JG, Sarkar A, Johnson AO (2001) Obstructive sleep apnoea and fetal death: successful treatment with continuous positive airway pressure. BJOG 108:543–544PubMed Brain KA, Thornton JG, Sarkar A, Johnson AO (2001) Obstructive sleep apnoea and fetal death: successful treatment with continuous positive airway pressure. BJOG 108:543–544PubMed
11.
Zurück zum Zitat Guilleminault C, Querra-Salva M, Chowdhuri S, Poyares D (2000) Normal pregnancy, daytime sleeping, snoring and blood pressure. Sleep Med 1:289–297CrossRefPubMed Guilleminault C, Querra-Salva M, Chowdhuri S, Poyares D (2000) Normal pregnancy, daytime sleeping, snoring and blood pressure. Sleep Med 1:289–297CrossRefPubMed
12.
Zurück zum Zitat Yin TT, Williams N, Burton C, Ong SS, Loughna P, Britton JR, Thornton JG (2008) Hypertension, fetal growth restriction and obstructive sleep apnoea in pregnancy. Eur J Obstet Gynecol Reprod Biol 141:35–38CrossRefPubMed Yin TT, Williams N, Burton C, Ong SS, Loughna P, Britton JR, Thornton JG (2008) Hypertension, fetal growth restriction and obstructive sleep apnoea in pregnancy. Eur J Obstet Gynecol Reprod Biol 141:35–38CrossRefPubMed
14.
Zurück zum Zitat Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7:359–371CrossRefPubMed Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7:359–371CrossRefPubMed
15.
Zurück zum Zitat Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi AS (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649–658CrossRefPubMedPubMedCentral Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi AS (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649–658CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592–1594CrossRefPubMed Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592–1594CrossRefPubMed
17.
Zurück zum Zitat Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai Baha M, Sukhatme Vikas P, AnanthKarumanchi S (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683CrossRefPubMed Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai Baha M, Sukhatme Vikas P, AnanthKarumanchi S (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683CrossRefPubMed
18.
Zurück zum Zitat Gilbert JS, Babcock SA, Granger JP (2007) Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50:1142–1147CrossRefPubMed Gilbert JS, Babcock SA, Granger JP (2007) Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50:1142–1147CrossRefPubMed
19.
Zurück zum Zitat Allahdadi KJ, Walker BR, Kanagy NL (2005) Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45:705–709CrossRefPubMed Allahdadi KJ, Walker BR, Kanagy NL (2005) Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45:705–709CrossRefPubMed
20.
Zurück zum Zitat Castro-Grattoni AL, Suarez-Giron M, Benitez I, Torres M, Almendros I, Farre R, Montserrat JM, Dalmases M, Gozal D, Sánchez-de-la-Torre M, Spanish Sleep Network (2020) Effect of age on the cardiovascular remodelling induced by chronic intermittent hypoxia as a murine model of sleep apnoea. Respirology 25:312–320CrossRefPubMed Castro-Grattoni AL, Suarez-Giron M, Benitez I, Torres M, Almendros I, Farre R, Montserrat JM, Dalmases M, Gozal D, Sánchez-de-la-Torre M, Spanish Sleep Network (2020) Effect of age on the cardiovascular remodelling induced by chronic intermittent hypoxia as a murine model of sleep apnoea. Respirology 25:312–320CrossRefPubMed
21.
Zurück zum Zitat Badran M, Yassin BA, Lin DTS, Kobor MS, Ayas N, Laher I (2019) Gestational intermittent hypoxia induces endothelial dysfunction, reduces perivascular adiponectin and causes epigenetic changes in adult male offspring. J Physiol 597:5349–5364CrossRefPubMed Badran M, Yassin BA, Lin DTS, Kobor MS, Ayas N, Laher I (2019) Gestational intermittent hypoxia induces endothelial dysfunction, reduces perivascular adiponectin and causes epigenetic changes in adult male offspring. J Physiol 597:5349–5364CrossRefPubMed
22.
Zurück zum Zitat Badran M, Abuyassin B, Ayas N, Laher I (2019) Intermittent hypoxia impairs uterine artery function in pregnant mice. J Physiol 597(10):2639–2650CrossRefPubMedPubMedCentral Badran M, Abuyassin B, Ayas N, Laher I (2019) Intermittent hypoxia impairs uterine artery function in pregnant mice. J Physiol 597(10):2639–2650CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Shibuya M (2013) Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem 153(1):13–19CrossRefPubMed Shibuya M (2013) Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem 153(1):13–19CrossRefPubMed
24.
Zurück zum Zitat Melincovici CS, Boşca AB, Şuşman S, Mărginean M, Mihu C, Istrate M, Moldovan IM, Roman AL, Mihu CM (2018) Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol 59(2):455–467PubMed Melincovici CS, Boşca AB, Şuşman S, Mărginean M, Mihu C, Istrate M, Moldovan IM, Roman AL, Mihu CM (2018) Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol 59(2):455–467PubMed
25.
Zurück zum Zitat Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60CrossRefPubMed Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60CrossRefPubMed
26.
Zurück zum Zitat Tsiamis AC, Morris PN, Marron MB, Brindle NP (2002) Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex. Microvasc Res 63:149–158CrossRefPubMed Tsiamis AC, Morris PN, Marron MB, Brindle NP (2002) Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex. Microvasc Res 63:149–158CrossRefPubMed
27.
Zurück zum Zitat Marron MB, Singh H, Tahir TA, Kavumkal J, Kim HZ, Kim HZ, Koh GY, Brindle NPJ (2007) Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J Biol Chem 282:30509–30517CrossRefPubMed Marron MB, Singh H, Tahir TA, Kavumkal J, Kim HZ, Kim HZ, Koh GY, Brindle NPJ (2007) Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J Biol Chem 282:30509–30517CrossRefPubMed
Metadaten
Titel
Gestational chronic intermittent hypoxia induces hypertension, proteinuria, and fetal growth restriction in mice
verfasst von
Cuilian Weng
Long Huang
Hangwei Feng
Quanying He
Xingsheng Lin
Tingting Jiang
Jian Lin
Xincai Wang
Qinghua Liu
Publikationsdatum
29.11.2021
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 4/2022
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-021-02529-3

Weitere Artikel der Ausgabe 4/2022

Sleep and Breathing 4/2022 Zur Ausgabe

Sleep Breathing Physiology and Disorders • Original Article

Supine sleep patterns as a part of phenotyping patients with sleep apnea—a pilot study

Sleep Breathing Physiology and Disorders • Review

Review of the prevalence, pathogenesis and management of OSA-COPD overlap

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.